Open AccessBenefits of capecitabine in hormone receptor-positive compared to hormone receptor-negative breast cancer
Publication year - 2022
Publication title -
sovremennaâ onkologiâ
Language(s) - English
Resource type - Journals
eISSN - 1815-1442
pISSN - 1815-1434
DOI - 10.26442/18151434.2022.2.201727
Subject(s) - capecitabine , hormone receptor , medicine , breast cancer , hormone , oncology , receptor , hormone therapy , cancer , gynecology , endocrinology , colorectal cancer